| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Propylene Glycols | 4 | 2017 | 30 | 1.260 |
Why?
|
| Neurons | 14 | 2017 | 1546 | 1.260 |
Why?
|
| Polyethylene Glycols | 4 | 2017 | 363 | 1.060 |
Why?
|
| Hippocampus | 8 | 2016 | 442 | 0.950 |
Why?
|
| Mitochondria | 7 | 2017 | 535 | 0.740 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2017 | 52 | 0.600 |
Why?
|
| Noninvasive Ventilation | 1 | 2017 | 24 | 0.600 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 6 | 2017 | 54 | 0.540 |
Why?
|
| Infant, Premature | 6 | 2017 | 290 | 0.520 |
Why?
|
| Bronchopulmonary Dysplasia | 3 | 2011 | 39 | 0.520 |
Why?
|
| Nitric Oxide | 5 | 2010 | 278 | 0.510 |
Why?
|
| Neuroprotective Agents | 2 | 2008 | 94 | 0.510 |
Why?
|
| Rats | 16 | 2017 | 3990 | 0.410 |
Why?
|
| Poloxamer | 3 | 2018 | 29 | 0.380 |
Why?
|
| Myocytes, Smooth Muscle | 5 | 2013 | 132 | 0.340 |
Why?
|
| Apoptosis | 2 | 2013 | 1683 | 0.340 |
Why?
|
| Rats, Sprague-Dawley | 8 | 2017 | 1219 | 0.340 |
Why?
|
| Central Nervous System Diseases | 1 | 2008 | 52 | 0.330 |
Why?
|
| Hypoxia | 4 | 2016 | 641 | 0.320 |
Why?
|
| Infant, Newborn | 9 | 2017 | 2379 | 0.310 |
Why?
|
| Reactive Oxygen Species | 7 | 2013 | 480 | 0.290 |
Why?
|
| Sumoylation | 3 | 2016 | 18 | 0.280 |
Why?
|
| Carotid Artery, Common | 1 | 2006 | 29 | 0.280 |
Why?
|
| Mitochondrial Membranes | 2 | 2017 | 14 | 0.270 |
Why?
|
| Cell Hypoxia | 4 | 2016 | 164 | 0.260 |
Why?
|
| Pulmonary Artery | 5 | 2013 | 306 | 0.250 |
Why?
|
| Cells, Cultured | 9 | 2017 | 2818 | 0.250 |
Why?
|
| Ischemic Attack, Transient | 1 | 2006 | 181 | 0.250 |
Why?
|
| N-Methylaspartate | 2 | 2001 | 51 | 0.240 |
Why?
|
| Excitatory Amino Acid Agonists | 2 | 2001 | 45 | 0.240 |
Why?
|
| Animals | 25 | 2018 | 26582 | 0.240 |
Why?
|
| Brain Injuries | 1 | 2006 | 161 | 0.230 |
Why?
|
| Synaptic Transmission | 3 | 2010 | 222 | 0.230 |
Why?
|
| Gerbillinae | 2 | 2017 | 12 | 0.220 |
Why?
|
| Cell Survival | 4 | 2017 | 969 | 0.220 |
Why?
|
| Muscle, Smooth, Vascular | 3 | 2013 | 231 | 0.210 |
Why?
|
| Cell Membrane | 5 | 2018 | 666 | 0.210 |
Why?
|
| Potassium Channels, Tandem Pore Domain | 2 | 2012 | 16 | 0.200 |
Why?
|
| Patch-Clamp Techniques | 5 | 2016 | 396 | 0.200 |
Why?
|
| Membrane Potentials | 5 | 2013 | 435 | 0.200 |
Why?
|
| Phospholipids | 2 | 2012 | 111 | 0.200 |
Why?
|
| SUMO-1 Protein | 2 | 2011 | 16 | 0.200 |
Why?
|
| Neurotoxins | 1 | 2000 | 49 | 0.190 |
Why?
|
| Intracellular Membranes | 1 | 2000 | 117 | 0.190 |
Why?
|
| Synaptic Vesicles | 2 | 2010 | 32 | 0.190 |
Why?
|
| Calcium | 6 | 2013 | 1156 | 0.180 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 2 | 2017 | 93 | 0.170 |
Why?
|
| Animals, Newborn | 1 | 2000 | 510 | 0.170 |
Why?
|
| Superoxides | 3 | 2013 | 73 | 0.170 |
Why?
|
| Superoxide Dismutase-1 | 1 | 2018 | 48 | 0.160 |
Why?
|
| Developmental Disabilities | 3 | 2010 | 195 | 0.160 |
Why?
|
| Mice | 11 | 2018 | 11352 | 0.160 |
Why?
|
| Child Development | 2 | 2009 | 163 | 0.160 |
Why?
|
| NAV1.2 Voltage-Gated Sodium Channel | 1 | 2016 | 5 | 0.150 |
Why?
|
| Serum Albumin, Bovine | 1 | 2016 | 45 | 0.150 |
Why?
|
| Palmitic Acid | 1 | 2016 | 26 | 0.150 |
Why?
|
| Surface-Active Agents | 2 | 2018 | 59 | 0.150 |
Why?
|
| Osteonectin | 1 | 2016 | 22 | 0.150 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2017 | 1961 | 0.150 |
Why?
|
| Infant, Extremely Premature | 1 | 2016 | 24 | 0.150 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2016 | 36 | 0.140 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2018 | 182 | 0.140 |
Why?
|
| Substrate Specificity | 1 | 2017 | 347 | 0.140 |
Why?
|
| Aging | 1 | 2000 | 691 | 0.140 |
Why?
|
| Fluorescence Resonance Energy Transfer | 4 | 2012 | 94 | 0.140 |
Why?
|
| White Matter | 1 | 2016 | 80 | 0.140 |
Why?
|
| Administration, Inhalation | 4 | 2010 | 188 | 0.140 |
Why?
|
| Lipid Metabolism | 1 | 2016 | 196 | 0.130 |
Why?
|
| Cerebellum | 2 | 2016 | 247 | 0.130 |
Why?
|
| Pilot Projects | 1 | 2017 | 839 | 0.120 |
Why?
|
| Movement | 1 | 2016 | 299 | 0.120 |
Why?
|
| Peroxiredoxins | 1 | 2013 | 13 | 0.120 |
Why?
|
| Sirtuin 3 | 1 | 2013 | 29 | 0.120 |
Why?
|
| Caspase 1 | 1 | 2013 | 18 | 0.120 |
Why?
|
| Amino Acid Chloromethyl Ketones | 1 | 2013 | 25 | 0.120 |
Why?
|
| Cytochromes c | 1 | 2013 | 27 | 0.120 |
Why?
|
| Caspase Inhibitors | 1 | 2013 | 33 | 0.120 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2013 | 47 | 0.120 |
Why?
|
| Primary Cell Culture | 1 | 2013 | 72 | 0.120 |
Why?
|
| Oxygen | 2 | 2013 | 726 | 0.110 |
Why?
|
| Electron Transport Complex III | 1 | 2013 | 12 | 0.110 |
Why?
|
| Male | 11 | 2018 | 40965 | 0.110 |
Why?
|
| Neuroblastoma | 1 | 2016 | 374 | 0.110 |
Why?
|
| Pulmonary Circulation | 1 | 2013 | 86 | 0.110 |
Why?
|
| Microscopy, Confocal | 3 | 2012 | 268 | 0.110 |
Why?
|
| Liposomes | 1 | 2012 | 91 | 0.110 |
Why?
|
| Action Potentials | 1 | 2016 | 573 | 0.110 |
Why?
|
| Fetus | 1 | 2013 | 226 | 0.110 |
Why?
|
| Nerve Net | 1 | 2016 | 366 | 0.110 |
Why?
|
| Green Fluorescent Proteins | 2 | 2010 | 305 | 0.110 |
Why?
|
| Multiprotein Complexes | 1 | 2012 | 95 | 0.110 |
Why?
|
| Enzyme Activation | 1 | 2013 | 692 | 0.100 |
Why?
|
| Humans | 15 | 2018 | 86643 | 0.100 |
Why?
|
| Shab Potassium Channels | 1 | 2011 | 29 | 0.100 |
Why?
|
| Dopamine | 2 | 2004 | 275 | 0.100 |
Why?
|
| Signal Transduction | 2 | 2013 | 3241 | 0.100 |
Why?
|
| Etomidate | 1 | 2010 | 11 | 0.100 |
Why?
|
| Anesthetics, Intravenous | 1 | 2010 | 41 | 0.100 |
Why?
|
| Unilamellar Liposomes | 1 | 2010 | 4 | 0.100 |
Why?
|
| Propofol | 1 | 2010 | 89 | 0.090 |
Why?
|
| Glucose | 1 | 2013 | 638 | 0.090 |
Why?
|
| Chloride Channels | 2 | 2008 | 42 | 0.090 |
Why?
|
| Infant, Premature, Diseases | 1 | 2010 | 78 | 0.090 |
Why?
|
| Vasodilator Agents | 1 | 2010 | 152 | 0.090 |
Why?
|
| Subcellular Fractions | 1 | 2009 | 93 | 0.090 |
Why?
|
| Reading | 1 | 2009 | 30 | 0.090 |
Why?
|
| Hypertension, Pulmonary | 1 | 2013 | 346 | 0.090 |
Why?
|
| Nerve Tissue Proteins | 1 | 2012 | 503 | 0.090 |
Why?
|
| Lung | 3 | 2013 | 1170 | 0.090 |
Why?
|
| Cricetulus | 3 | 2016 | 126 | 0.080 |
Why?
|
| Protein Multimerization | 1 | 2010 | 173 | 0.080 |
Why?
|
| CHO Cells | 3 | 2016 | 187 | 0.080 |
Why?
|
| Isoflurane | 1 | 2009 | 64 | 0.080 |
Why?
|
| Mutation | 2 | 2018 | 3968 | 0.080 |
Why?
|
| Anesthetics, Inhalation | 1 | 2009 | 95 | 0.080 |
Why?
|
| Chloride Channel Agonists | 1 | 2008 | 5 | 0.080 |
Why?
|
| Nervous System | 1 | 2008 | 86 | 0.080 |
Why?
|
| Acidosis | 1 | 2008 | 55 | 0.080 |
Why?
|
| Platelet Activating Factor | 1 | 2008 | 53 | 0.080 |
Why?
|
| Premature Birth | 1 | 2009 | 113 | 0.080 |
Why?
|
| Lipid Peroxidation | 2 | 2012 | 44 | 0.080 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2006 | 87 | 0.070 |
Why?
|
| Pregnancy | 1 | 2013 | 2894 | 0.070 |
Why?
|
| Heart | 1 | 2008 | 539 | 0.070 |
Why?
|
| Female | 11 | 2016 | 44532 | 0.070 |
Why?
|
| Barbiturates | 1 | 2005 | 12 | 0.070 |
Why?
|
| Coumarins | 1 | 2005 | 13 | 0.070 |
Why?
|
| Risk Factors | 3 | 2011 | 5417 | 0.070 |
Why?
|
| Ethanolamines | 1 | 2005 | 32 | 0.070 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 2 | 2006 | 87 | 0.060 |
Why?
|
| Chi-Square Distribution | 1 | 2006 | 364 | 0.060 |
Why?
|
| Functional Laterality | 1 | 2006 | 201 | 0.060 |
Why?
|
| Electrophysiology | 2 | 2008 | 401 | 0.060 |
Why?
|
| Isoxazoles | 1 | 2005 | 77 | 0.060 |
Why?
|
| Electron Transport Complex I | 1 | 2004 | 28 | 0.060 |
Why?
|
| Nerve Degeneration | 1 | 2004 | 83 | 0.060 |
Why?
|
| Synapses | 1 | 2006 | 265 | 0.060 |
Why?
|
| Disease Models, Animal | 2 | 2013 | 2232 | 0.060 |
Why?
|
| Epithelial Cells | 1 | 2008 | 669 | 0.060 |
Why?
|
| Analysis of Variance | 1 | 2006 | 912 | 0.060 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2006 | 332 | 0.060 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2013 | 151 | 0.050 |
Why?
|
| Leukomalacia, Periventricular | 3 | 2009 | 18 | 0.050 |
Why?
|
| Neuropsychological Tests | 3 | 2009 | 502 | 0.050 |
Why?
|
| Mice, Transgenic | 2 | 2018 | 1540 | 0.050 |
Why?
|
| Vasoconstriction | 2 | 2013 | 93 | 0.050 |
Why?
|
| Cerebral Palsy | 2 | 2016 | 90 | 0.050 |
Why?
|
| Apoptosis Inducing Factor | 1 | 2001 | 6 | 0.050 |
Why?
|
| Cell Membrane Structures | 1 | 2001 | 3 | 0.050 |
Why?
|
| Islets of Langerhans | 1 | 2005 | 544 | 0.050 |
Why?
|
| Free Radical Scavengers | 1 | 2001 | 59 | 0.050 |
Why?
|
| Flavoproteins | 1 | 2001 | 25 | 0.050 |
Why?
|
| Mesencephalon | 1 | 2001 | 64 | 0.050 |
Why?
|
| Cytosol | 2 | 2013 | 189 | 0.050 |
Why?
|
| Cytoprotection | 1 | 2001 | 47 | 0.050 |
Why?
|
| Osmolar Concentration | 1 | 2000 | 181 | 0.050 |
Why?
|
| 1-Methyl-4-phenylpyridinium | 1 | 2000 | 12 | 0.050 |
Why?
|
| NADH Dehydrogenase | 1 | 2000 | 22 | 0.050 |
Why?
|
| Herbicides | 1 | 2000 | 35 | 0.050 |
Why?
|
| Necrosis | 1 | 2001 | 204 | 0.050 |
Why?
|
| Drug Interactions | 1 | 2001 | 248 | 0.050 |
Why?
|
| Pyramidal Cells | 1 | 2000 | 80 | 0.050 |
Why?
|
| Severity of Illness Index | 1 | 2006 | 1801 | 0.050 |
Why?
|
| PC12 Cells | 2 | 2010 | 115 | 0.050 |
Why?
|
| Blotting, Western | 2 | 2012 | 782 | 0.050 |
Why?
|
| Parkinson Disease | 1 | 2001 | 132 | 0.050 |
Why?
|
| Drug Resistance | 1 | 2000 | 256 | 0.050 |
Why?
|
| Cricetinae | 2 | 2011 | 560 | 0.050 |
Why?
|
| Time Factors | 2 | 2006 | 5210 | 0.040 |
Why?
|
| Oxidation-Reduction | 2 | 2010 | 373 | 0.040 |
Why?
|
| Homeostasis | 1 | 2000 | 409 | 0.040 |
Why?
|
| Models, Neurological | 2 | 2016 | 405 | 0.040 |
Why?
|
| Fluorescent Dyes | 2 | 2010 | 242 | 0.040 |
Why?
|
| Follow-Up Studies | 3 | 2010 | 3640 | 0.040 |
Why?
|
| Child, Preschool | 3 | 2009 | 3612 | 0.040 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2016 | 63 | 0.040 |
Why?
|
| Electrophysiological Phenomena | 1 | 2016 | 49 | 0.040 |
Why?
|
| Birth Weight | 2 | 2009 | 145 | 0.040 |
Why?
|
| Spectrum Analysis | 1 | 2016 | 118 | 0.030 |
Why?
|
| Biophysics | 1 | 2016 | 152 | 0.030 |
Why?
|
| Mice, Knockout | 2 | 2013 | 1924 | 0.030 |
Why?
|
| Embryo, Mammalian | 1 | 2016 | 207 | 0.030 |
Why?
|
| Drug Combinations | 1 | 2016 | 224 | 0.030 |
Why?
|
| Neurotransmitter Agents | 1 | 2016 | 106 | 0.030 |
Why?
|
| Electric Stimulation | 1 | 2016 | 347 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2016 | 4213 | 0.030 |
Why?
|
| Genetic Therapy | 1 | 2016 | 342 | 0.030 |
Why?
|
| Child | 3 | 2010 | 6927 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2001 | 1196 | 0.030 |
Why?
|
| Biomarkers | 1 | 2000 | 1718 | 0.030 |
Why?
|
| Mitochondria, Muscle | 1 | 2013 | 26 | 0.030 |
Why?
|
| Hypertrophy, Right Ventricular | 1 | 2013 | 33 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 2 | 2013 | 3092 | 0.030 |
Why?
|
| Double-Blind Method | 2 | 2010 | 1823 | 0.030 |
Why?
|
| Halothane | 1 | 2012 | 12 | 0.030 |
Why?
|
| Rotenone | 2 | 2004 | 17 | 0.030 |
Why?
|
| Calcium Signaling | 1 | 2013 | 129 | 0.030 |
Why?
|
| Cell Movement | 1 | 2016 | 758 | 0.030 |
Why?
|
| Amidines | 1 | 2012 | 2 | 0.030 |
Why?
|
| Calorimetry | 1 | 2012 | 15 | 0.030 |
Why?
|
| Adsorption | 1 | 2012 | 54 | 0.030 |
Why?
|
| Dimerization | 1 | 2012 | 143 | 0.030 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2013 | 214 | 0.030 |
Why?
|
| Scattering, Radiation | 1 | 2012 | 114 | 0.030 |
Why?
|
| In Situ Hybridization | 1 | 2012 | 307 | 0.030 |
Why?
|
| Cell Line | 2 | 2008 | 2468 | 0.030 |
Why?
|
| Potassium | 1 | 2012 | 281 | 0.030 |
Why?
|
| Thermodynamics | 1 | 2012 | 309 | 0.030 |
Why?
|
| Light | 1 | 2012 | 289 | 0.020 |
Why?
|
| Biocompatible Materials | 1 | 2012 | 193 | 0.020 |
Why?
|
| Osmosis | 1 | 2010 | 6 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2016 | 2426 | 0.020 |
Why?
|
| Water | 1 | 2012 | 277 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2016 | 1578 | 0.020 |
Why?
|
| Lysine | 1 | 2011 | 147 | 0.020 |
Why?
|
| Catalase | 1 | 2009 | 48 | 0.020 |
Why?
|
| Mental Status Schedule | 1 | 2009 | 26 | 0.020 |
Why?
|
| Infant | 1 | 2016 | 3046 | 0.020 |
Why?
|
| Incidence | 2 | 2005 | 1577 | 0.020 |
Why?
|
| Cell Compartmentation | 1 | 2009 | 69 | 0.020 |
Why?
|
| Nervous System Diseases | 1 | 2010 | 151 | 0.020 |
Why?
|
| Syntaxin 1 | 1 | 2009 | 8 | 0.020 |
Why?
|
| Cyclobutanes | 1 | 2009 | 7 | 0.020 |
Why?
|
| Culture Media, Conditioned | 1 | 2009 | 104 | 0.020 |
Why?
|
| SNARE Proteins | 1 | 2009 | 26 | 0.020 |
Why?
|
| Models, Biological | 1 | 2016 | 1749 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2009 | 229 | 0.020 |
Why?
|
| Renal Artery | 1 | 2009 | 64 | 0.020 |
Why?
|
| Social Class | 1 | 2009 | 128 | 0.020 |
Why?
|
| Cell Differentiation | 2 | 2006 | 1458 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2010 | 425 | 0.020 |
Why?
|
| Sodium-Hydrogen Exchanger 1 | 1 | 2008 | 4 | 0.020 |
Why?
|
| 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid | 1 | 2008 | 17 | 0.020 |
Why?
|
| Fura-2 | 1 | 2008 | 22 | 0.020 |
Why?
|
| Egtazic Acid | 1 | 2008 | 34 | 0.020 |
Why?
|
| DNA Fragmentation | 1 | 2008 | 63 | 0.020 |
Why?
|
| Sodium-Hydrogen Exchangers | 1 | 2008 | 79 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2009 | 557 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2008 | 159 | 0.020 |
Why?
|
| Chelating Agents | 1 | 2008 | 69 | 0.020 |
Why?
|
| Students | 1 | 2009 | 147 | 0.020 |
Why?
|
| ROC Curve | 1 | 2009 | 752 | 0.020 |
Why?
|
| Synaptosomes | 1 | 2006 | 9 | 0.020 |
Why?
|
| Synaptic Membranes | 1 | 2006 | 14 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2008 | 493 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2009 | 567 | 0.020 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2006 | 21 | 0.020 |
Why?
|
| RNA Interference | 1 | 2008 | 369 | 0.020 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2006 | 85 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2009 | 999 | 0.020 |
Why?
|
| Chlorides | 1 | 2006 | 103 | 0.020 |
Why?
|
| Brain | 1 | 2016 | 2216 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2009 | 1019 | 0.020 |
Why?
|
| Glutamic Acid | 1 | 2006 | 152 | 0.020 |
Why?
|
| Hearing Loss, Bilateral | 1 | 2005 | 9 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2010 | 7993 | 0.020 |
Why?
|
| Thiobarbiturates | 1 | 2005 | 5 | 0.020 |
Why?
|
| Blindness | 1 | 2005 | 41 | 0.020 |
Why?
|
| Oscillometry | 1 | 2005 | 25 | 0.020 |
Why?
|
| Coloring Agents | 1 | 2005 | 64 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2009 | 1673 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2006 | 504 | 0.020 |
Why?
|
| Age Factors | 1 | 2009 | 1851 | 0.020 |
Why?
|
| Oxidative Phosphorylation | 1 | 2004 | 49 | 0.020 |
Why?
|
| Educational Status | 1 | 2005 | 188 | 0.020 |
Why?
|
| Intestines | 1 | 2008 | 411 | 0.020 |
Why?
|
| Peptides | 1 | 2008 | 639 | 0.020 |
Why?
|
| Linear Models | 1 | 2005 | 421 | 0.020 |
Why?
|
| Intellectual Disability | 1 | 2005 | 186 | 0.020 |
Why?
|
| Glycolysis | 1 | 2004 | 129 | 0.010 |
Why?
|
| Infant, Low Birth Weight | 1 | 2003 | 58 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2008 | 589 | 0.010 |
Why?
|
| Gene Expression | 1 | 2008 | 1284 | 0.010 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2003 | 60 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 2005 | 989 | 0.010 |
Why?
|
| Antioxidants | 1 | 2004 | 223 | 0.010 |
Why?
|
| Intracranial Hemorrhages | 1 | 2003 | 120 | 0.010 |
Why?
|
| Cerebral Hemorrhage | 1 | 2005 | 325 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2004 | 447 | 0.010 |
Why?
|
| Lung Diseases | 1 | 2003 | 263 | 0.010 |
Why?
|
| Respiration, Artificial | 1 | 2003 | 334 | 0.010 |
Why?
|
| Receptors, Dopamine | 1 | 2000 | 38 | 0.010 |
Why?
|
| Glutathione | 1 | 2000 | 104 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2003 | 971 | 0.010 |
Why?
|
| Cell Death | 1 | 2000 | 256 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2001 | 729 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2000 | 1753 | 0.010 |
Why?
|